Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.

Hypertension (Dallas, Tex. : 1979) - 1 Jan 2008

Byrd James Brian, Touzin Karine, Sile Saba, Gainer James V, Yu Chang, Nadeau John, Adam Albert, Brown Nancy J

Abstract excerpt

Angioedema is a potentially life-threatening adverse effect of angiotensin-converting enzyme inhibitors. Bradykinin and substance P, substrates of angiotensin-converting enzyme, increase vascular permeability and cause tissue edema in animals. Studies indicate that amino-terminal degradation of these peptides, by aminopeptidase P and dipeptidyl peptidase IV, may be impaired in individuals with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angioedema
Share to Angiotensin-Converting Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens

Share to Bradykinin

Share to Dipeptidyl Peptidase 4

Share to Hypertension

Share to Peptidyl-Dipeptidase A

Share to Substance P

Source

Open in PubMed Open full text

Identifiers

PMID: 18025295
DOI: 10.1161/HYPERTENSIONAHA.107.096552
PMCID: PMC2749928

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.PMID 18025295Read ↗

Angiotensin-converting enzyme inhibitor-associated angioedema.Semantic proximity Read ↗

Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?Semantic proximity Read ↗

Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications.Semantic proximity Read ↗

Drugs of the Kallikrein-Kinin System: An OverviewSemantic proximity Read ↗

Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.Semantic proximity Read ↗

ACE inhibitor-mediated angioedemaSemantic proximity Read ↗

Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.Semantic proximity Read ↗

Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema.Semantic proximity Read ↗

Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema.Semantic proximity Read ↗

The effect of recombinant aminopeptidase A on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan.Semantic proximity Read ↗

Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.